Alexis Hermida

884 total citations
37 papers, 233 citations indexed

About

Alexis Hermida is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Alexis Hermida has authored 37 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cardiology and Cardiovascular Medicine, 7 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Alexis Hermida's work include Cardiac electrophysiology and arrhythmias (11 papers), Cardiac Arrhythmias and Treatments (9 papers) and Atrial Fibrillation Management and Outcomes (8 papers). Alexis Hermida is often cited by papers focused on Cardiac electrophysiology and arrhythmias (11 papers), Cardiac Arrhythmias and Treatments (9 papers) and Atrial Fibrillation Management and Outcomes (8 papers). Alexis Hermida collaborates with scholars based in France, United States and Belgium. Alexis Hermida's co-authors include Maciej Kubala, Jean‐Sylvain Hermida, Didier Klug, Philippe Charron, Véronique Fressart, Estelle Gandjbakhch, Sarah Traullé, Christophe Beyls, Philippe Chevalier and Nicolas Mansencal and has published in prestigious journals such as Circulation, European Heart Journal and The American Journal of Cardiology.

In The Last Decade

Alexis Hermida

31 papers receiving 232 citations

Peers

Alexis Hermida
Alexis Hermida
Citations per year, relative to Alexis Hermida Alexis Hermida (= 1×) peers Filippo Zilio

Countries citing papers authored by Alexis Hermida

Since Specialization
Citations

This map shows the geographic impact of Alexis Hermida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexis Hermida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexis Hermida more than expected).

Fields of papers citing papers by Alexis Hermida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexis Hermida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexis Hermida. The network helps show where Alexis Hermida may publish in the future.

Co-authorship network of co-authors of Alexis Hermida

This figure shows the co-authorship network connecting the top 25 collaborators of Alexis Hermida. A scholar is included among the top collaborators of Alexis Hermida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexis Hermida. Alexis Hermida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hermida, Alexis, Alice Maltret, Isabelle Denjoy, et al.. (2025). Clinical presentation and outcomes of patients with biallelic SCN5A variants: A systematic review. Heart Rhythm O2. 6(9). 1372–1381.
2.
Bouvagnet, Patrice, Anne‐Claire Bréhin, Alexis Hermida, et al.. (2025). MYH6 in Congenital Heart Defects: A Genotype–Phenotype Characterization in a French Cohort. Pediatric Cardiology.
3.
Laredo, Mikaël, Etienne Charpentier, Annamaria Martino, et al.. (2025). Imaging features of desmoplakin arrhythmogenic cardiomyopathy: A comparative cardiovascular magnetic resonance study. Journal of Cardiovascular Magnetic Resonance. 27(1). 101867–101867.
4.
Hermida, Alexis, Flavie Ader, Guillaume Jedraszak, et al.. (2025). Prognosis for loss-of-function vs hot-spot variants in RBM20-related cardiomyopathy. Heart Rhythm. 22(10). e1040–e1042.
7.
Beyls, Christophe, Alexis Hermida, A Fournier, et al.. (2024). Left atrial strain analysis and new-onset atrial fibrillation in patients with ST-segment elevation myocardial infarction: A prospective echocardiography study. Archives of cardiovascular diseases. 117(4). 266–274. 3 indexed citations
8.
Guedeney, Paul, Julio I. Farjat‐Pasos, Vincent Roule, et al.. (2023). Impact of the antiplatelet strategy following patent foramen ovale percutaneous closure. European Heart Journal. 44(Supplement_2). 1 indexed citations
9.
Delinière, Antoine, Claudia Herrera‐Siklody, Alexis Hermida, et al.. (2023). Phenotypic Characterization of Timothy Syndrome Caused by the CACNA1C p.Gly402Ser Variant. Circulation Genomic and Precision Medicine. 16(3). 280–282. 5 indexed citations
10.
Beyls, Christophe, Alexis Hermida, Pierre Huette, et al.. (2022). Association between the Right Ventricular Longitudinal Shortening Fraction and Mortality in Acute Respiratory Distress Syndrome Related to COVID-19 Infection: A Prospective Study. Journal of Clinical Medicine. 11(9). 2625–2625. 5 indexed citations
11.
Hermida, Alexis, et al.. (2022). Sex Differences in the Outcomes of Cryoablation for Atrial Fibrillation. Frontiers in Cardiovascular Medicine. 9. 893553–893553. 9 indexed citations
12.
Hermida, Alexis, et al.. (2021). Results and Predictive Factors After One Cryoablation for Persistent Atrial Fibrillation. The American Journal of Cardiology. 159. 65–71. 1 indexed citations
13.
Hermida, Alexis, et al.. (2021). Use of ranolazine as rescue therapy in a patient with Timothy syndrome type 2. Revista Española de Cardiología (English Edition). 75(5). 447–448. 3 indexed citations
14.
Hermida, Alexis, Guillaume Jedraszak, Maciej Kubala, et al.. (2021). Long-term follow-up of a patient with type 2 Timothy syndrome and the partial efficacy of mexiletine. Gene. 777. 145465–145465. 9 indexed citations
15.
Beyls, Christophe, Alexis Hermida, Pierre Huette, et al.. (2021). Automated left atrial strain analysis for predicting atrial fibrillation in severe COVID-19 pneumonia: a prospective study. Annals of Intensive Care. 11(1). 168–168. 12 indexed citations
16.
Hermida, Alexis, Véronique Fressart, Françoise Hidden‐Lucet, et al.. (2019). High Risk of Heart Failure Associated with Desmoglein-2 Mutations Compared to Plakophilin-2 Mutations in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia. European Journal of Heart Failure. 21(6). 792–800. 42 indexed citations
17.
Defaye, Pascal, Didier Klug, Frédéric Anselme, et al.. (2017). Recommendations for the implantation of leadless pacemakers from the French Working Group on Cardiac Pacing and Electrophysiology of the French Society of Cardiology. Archives of cardiovascular diseases. 111(1). 53–58. 7 indexed citations
18.
Boulé, Stéphane, Alexis Hermida, Philippe Mabo, et al.. (2016). Catheter ablation reduces ventricular tachycardia burden in patients with arrhythmogenic right ventricular cardiomyopathy: insights from a north-western French multicentre registry. EP Europace. 20(2). 362–369. 26 indexed citations
19.
Laurent, Gabriel, W. Amara, Jacques Mansourati, et al.. (2014). Role of patient education in the perception and acceptance of home monitoring after recent implantation of cardioverter defibrillators: The EDUCAT study. Archives of cardiovascular diseases. 107(10). 508–518. 9 indexed citations
20.
Hermida, Jean‐Sylvain, Isabelle Six, Carole Amant, et al.. (2010). Prospective Evaluation of the Familial Prevalence of the Brugada Syndrome. The American Journal of Cardiology. 106(12). 1758–1762. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026